Key facts
- VahatiCor’s last known valuation is $48.0M (Nov 2025).
- It has raised $29.7M across 1 recorded rounds; the latest was Early Stage VC ($21.2M) in Nov 2025.
- Notable investors include Kinled Holding, S3 Ventures, Intuitive Ventures, T45 Labs.
- VahatiCor has filed 1 Form D with the SEC, most recently Dec 2025 ($21.2M sold to 19 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for VahatiCor
Funding rounds
1 roundsAbout VahatiCor
Developer of a medical technology platform designed to alleviate the angina burden for patients with coronary microvascular dysfunction who have exhausted current medical therapies. The company offers smart, implantable flow-reduction devices that enable patients with coronary microvascular dysfunction to improve heart microperfusion and reclaim daily activities.
- Sector
- Healthcare
- HQ
- Santa Clara, CA, United States
- Founded
- 2018
- Employees
- 9
- Website
- vahaticor.com/
- Ownership
- Privately Held (backing)
VahatiCor doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VahatiCor shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VahatiCor in its N-PORT filings yet. We sweep new filings monthly.